The [68Ga]Ga-FAPi-04 PET/CT image depicted very intense tracer uptakes of all metastases (higher than those of PSMA and FDG), which suggests that in PCa, FAP-targeted radionuclide therapy (using molecules with longer retention times than those of FAPi-04) has the potential to overcome limitations related to tumour heterogeneity and an insufficient PSMA expression level. Here, FOLH1 is linked to neoplasm.